• Bieche I, Asselah T, Laurendeau I. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection[J]. Virology, 2005, 332(): 130-144. doi: 10.1016/j.virol.2004.11.009

  • Deng G, Zhou G, Zhang R. Regulatory polymorphisms in the promoter of CXCL10 gene and disease Progression in male hepatitis B virus carriers[J]. Gastroenterology, 2008, 134(): 716-726. doi: 10.1053/j.gastro.2007.12.044

  • Han M, Yan W, Guo W. Hepatitis B virus induced HFGl2 transcription is dependent on c-Ets-2 and MAPK signal pathway[J]. J Biol Chem, 2008, 283(): 32715-32729. doi: 10.1074/jbc.M806769200

  • Lasarte J J, Sarobe P, Boya P. A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage[J]. Hepatology, 2003, 37(): 461-470. doi: 10.1053/jhep.2003.50073

  • Liu M, Chan C W, McGilvray I. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications[J]. Expert Rev Mol Med, 2001, 28(): 1-19.

  • Luo Y, Luo J, Lin S. Clinical significance of serum interferon-inducible protein-10 and serial changes in patients with severe hepatitis B[J]. World J Gastroenterol, 2007, 15(): 2648-2651.

  • Marsden P A, Ning Q, Fung L S. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis[J]. J Clin Invest, 2003, 112(): 58-66. doi: 10.1172/JCI18114

  • Ning Q, Brown D, Parodo J. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response[J]. J Immunol, 1998, 160(): 3487-3493.

  • Ran Y, Li J, Yi X. Realtionship on serum level of interferon inducible protein 10 of viral hepatitis B and hepatic function norm[J]. Clinical Focus, 2008, 11(): 1543-1545.

  • Reiberger T, Aberle J H, Kundi M. CXCL10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection[J]. Antivir Ther, 2008, 13(): 969-976.

  • Shi L, He J, Chen Z. The expression and significance of chemokine interferon-inducible protein-10 (IP-10) in chronic hepatitis B patients[J]. Chin J Clini Hepatol, 2003, 19(): 220-221.

  • Vadan R, Gheorghe L, Becheanu G. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption[J]. Rom J Gastroenterol, 2003, 12(): 183-187.

  • Zhu C L, Yan W M, Zhu F. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis[J]. World J Gastroenterol, 2005, 11(): 6936-6940. doi: 10.3748/wjg.v11.i44.6936